SSY Group Wins China Approval for Bicarbonate Peritoneal Dialysis Solution

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • SSY Group secured China’s National Medical Products Administration approval to produce its 2,000-milliliter Peritoneal Dialysis Solution (Bicarbonate-G1.5%). * The treatment for chronic renal failure is the group’s first dialysis solution in dual-chamber bags. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261113-12411513), on November 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings